You are not logged in. | Log in
In Progress
Clinical

Identification of biomarkers of response to IFNg during endotoxin tolerance: application to septic shock - GSE46914

Purpose

The rapid development in septic patients of features of marked immunosuppression associated with increased risk of nosocomial infections and mortality represents the rational for the initiation of immune targeted treatments in sepsis. However, as there is no clinical sign of immune dysfunctions, the current challenge is to develop biomarkers that will help clinicians identify the patients that would benefit from immunotherapy and monitor its efficacy. Using an in vitro model of endotoxin tolerance (ET), a pivotal feature of sepsis-induced immunosuppression in monocytes, we identified using gene expression profiling by microarray a panel of transcripts associated with the development of ET which expression was restored after immunostimulation with interferon-gamma (IFN-?). These results were confirmed by qRT-PCR. Importantly, this short-list of markers was further evaluated in patients. Of these transcripts, six (TNFAIP6, FCN1, CXCL10, GBP1, CXCL5 and PID1) were differentially expressed in septic shock patients’ blood compared to healthy blood upon ex vivo LPS stimulation and were restored by IFN-?. In this study, by combining a microarray approach in an in vitro model and a validation in clinical samples, we identified a panel of six transcripts that could be used for the identification of septic patients eligible for IFNg therapy. The potential value of these markers should now be evaluated in a larger cohort of patients. Upon favorable results, they could serve as stratification tools prior to immunostimulatory treatment and to monitor drug efficacy.

Hypothesis

--

Experimental Design

PBMCs from 6 healthy donor were left unstimulated (medium) or with 1 shot of LPS (LPS unprimed), 2 shots of LPS (LPS primed) or 2 shots of LPS and Interferon gamma (LPS primed + IFNg).

Experimental Variables

Lipopolysaccharide exposure (2021 ICD-10-CM code* = Not Applicable)

Controls

--

Methods

Expression data were generated using the Robust Multi-array Average (RMA) method implemented in the Affymetrix package of the Bioconductor microarray analysis environment (http://www.bioconductor.org).

Additional Information

https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE46914

Microarray
Affymetrix HG-U133_Plus_2
24 Samples Loaded: 24
Human (Homo sapiens)
PBMC
Lipopolysaccharide exposure
Sample Set Spreadsheet
Please log in in order to upload files.
Samples Preview
Sample ID !Sample_title culture condition
GSM1141035 PBMCs_HV2_medium medium
GSM1141036 PBMCs_HV2_LPS unprimed LPS unprimed
GSM1141037 PBMCs_HV2_LPS primed LPS primed
GSM1141038 PBMCs_HV2_LPS primed+IFNg LPS primed + IFNg
GSM1141039 PBMCs_HV3_medium medium
Please log in in order to upload files.
File
Log2 Transformed
Raw Signal
  •   |  View in GXB »
Clinical Datasource
Links

Samples Viewer / Editor

All fields are editable except the "Sample ID" column. To edit a cell, click within the cell. To edit a "date" cell, click on the calendar icon. To cancel an edit, press the ESC key.

Sample ID !Sample Title Culture condition
GSM1141035
PBMCs_HV2_medium
medium
GSM1141036
PBMCs_HV2_LPS unprimed
LPS unprimed
GSM1141037
PBMCs_HV2_LPS primed
LPS primed
GSM1141038
PBMCs_HV2_LPS primed+IFNg
LPS primed + IFNg
GSM1141039
PBMCs_HV3_medium
medium
GSM1141040
PBMCs_HV3_LPS unprimed
LPS unprimed
GSM1141041
PBMCs_HV3_LPS primed
LPS primed
GSM1141042
PBMCs_HV3_LPS primed+IFNg
LPS primed + IFNg
GSM1141043
PBMCs_HV5_medium
medium
GSM1141044
PBMCs_HV5_LPS unprimed
LPS unprimed
GSM1141045
PBMCs_HV5_LPS primed
LPS primed
GSM1141046
PBMCs_HV5_LPS primed+IFNg
LPS primed + IFNg
GSM1141047
PBMCs_HV6_medium
medium
GSM1141048
PBMCs_HV6_LPS unprimed
LPS unprimed
GSM1141049
PBMCs_HV6_LPS primed
LPS primed
GSM1141050
PBMCs_HV6_LPS primed+IFNg
LPS primed + IFNg
GSM1141051
PBMCs_HV7_medium
medium
GSM1141052
PBMCs_HV7_LPS unprimed
LPS unprimed
GSM1141053
PBMCs_HV7_LPS primed
LPS primed
GSM1141054
PBMCs_HV7_LPS primed+IFNg
LPS primed + IFNg
GSM1141055
PBMCs_HV9_medium
medium
GSM1141056
PBMCs_HV9_LPS unprimed
LPS unprimed
GSM1141057
PBMCs_HV9_LPS primed
LPS primed
GSM1141058
PBMCs_HV9_LPS primed+IFNg
LPS primed + IFNg

Group Sets View in Gene Expression Browser

Name  
All Samples   View
Culture Conditions Default  View
In order to make new Group Sets or change settings, please log in.

Module Analysis

Group Set  
All Samples
Culture Conditions
Your bug report has been sent!